Next

Satire Dressed as Thriller

Michael Crichton spent his career asking what happens when science outruns wisdom, and Next represents his most explicitly polemical answer. Published two years before his death, the novel abandons the tight single-threat architecture of Jurassic Park and The Andromeda Strain in favor of a deliberately fractured multi-strand structure that mirrors the chaotic, litigious landscape of the biotech industry it critiques. Multiple storylines run in parallel: a man hunted by a biotech company that claims legal ownership of his cells, a researcher whose transgenic parrot begins speaking in full sentences, a humanzee hybrid named Dave being raised as a human child, and dozens of secondary characters—venture capitalists, patent lawyers, unscrupulous scientists, and ordinary patients—caught in the machinery of genetic commercialization. The satirical intent is never subtle. Crichton includes a lengthy author’s note at the end explicitly calling for reform of gene patent law, and fictional news items and case summaries appear throughout the novel, blurring the line between story and advocacy. For readers who share his concerns, the effect is galvanizing; for those seeking pure narrative immersion, it can feel didactic.

The Science and Its Discontents

Where Next succeeds most convincingly is in its portrait of a research ecosystem corrupted by financial incentives. Crichton did his homework: the gene patent disputes at the novel’s center are grounded in real legal controversies, and his depiction of how academic researchers, venture capital, and pharmaceutical companies interact around intellectual property is both accurate and damning. The novel captures how the promise of genetic medicine has been systematically compromised by the race to patent everything, resulting in a landscape where patients may not legally own the cells in their own bodies and where corporate interests can override scientific progress. These passages have gained relevance rather than lost it in the years since publication—landmark legal battles over gene patents continued to unfold for years after Crichton wrote about them. The more fanciful elements, a talking transgenic parrot with its dead researcher’s conversational patterns, a chimpanzee-human hybrid navigating a suburban school, function as absurdist parables that illuminate the same underlying questions about where genetic science is taking us.

A Flawed but Worthwhile Experiment

Next is an unusual entry in Crichton’s catalog, more essay than novel in its ambitions, more interested in making arguments than in creating the sustained tension that characterized his peak work. The structural fragmentation that serves the satirical purpose makes emotional engagement difficult; with so many storylines and characters, none gets the development needed to generate genuine investment. The novel is probably best understood as a companion piece to his better-crafted science thrillers—a place to encounter his research and arguments in concentrated form, even if the fictional execution is uneven. Readers who come to Next after Jurassic Park or Prey may be surprised by how different it feels. Those who read it knowing what it is—a polemical satire with thriller window dressing—will find much to engage with, even if they leave wishing the storytelling matched the intellectual ambition.

Our rating: 3.5/5 — A sharp satirical critique of the biotech industry’s ethical failures, hampered by a fragmented structure that prioritizes argument over narrative engagement.